Chronic Periodontitis, Chronic Periodontitis Wth Diabetes Mellitus, Gingival Regeneration, Metabolic Repair, Non-surgical Periodontal Treatment
Conditions
Keywords
Gingival Regeneration, Metabolic Repair, Non-Surgical Periodontal Treatment
Brief summary
This observational study documents the clinical outcomes of a proprietary, safe-to-swallow metabolic protocol for chronic gum disease. Based on 21 years of research and a focused 20-patient cohort, the study records visible clinical improvements in gingival inflammation and tissue color within 7 to 14 days. The protocol focuses on restoring the metabolic environment to achieve non-surgical periodontal pocket stabilization and natural tissue re-attachment.
Interventions
Topical application of a proprietary, 100% food-grade (GRAS) nutraceutical formulation specifically designed for rapid gingival tissue regeneration and inflammation reversal. Key Performance Indicators: Speed: Clinical onset of action visible within 3 days. Safety: Completely safe for ingestion (edible), eliminating common side effects of chemical antiseptics like staining or taste alteration. Efficacy: Significant reduction in redness and bleeding (BOP) within 7 to 14 days, as demonstrated in our cohort of 20+ subjects. Mechanism: Supports the natural healing of the gum 'peau' (epithelium) through host-response modulation rather than harsh disinfection.
Topical application of a proprietary, 100% food-grade (GRAS) nutraceutical formulation specifically designed for rapid gingival tissue regeneration and inflammation reversal.Key Performance Indicators: Speed: Clinical onset of action visible within 3 days. Safety: Completely safe for ingestion (edible), eliminating common side effects of chemical antiseptics like staining or taste alteration. Efficacy: Significant reduction in redness and bleeding (BOP) within 7 to 14 days, as demonstrated in our cohort of 20+ subjects. Mechanism: Supports the natural healing of the gum 'peau' (epithelium) through host-response modulation rather than harsh disinfection."
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients (18-75) with documented chronic periodontitis and pocket depths \>4mm.
Exclusion criteria
* Active oral malignancy or pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visible reduction in gingival inflammation and erythema (redness) observed within 7 to 14 days | 7 to 14 days |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of periodontal pocket depth reduction and tissue stability at 6 weeks | 6 weeks |
Countries
Algeria